Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03001167 · ClinicalTrials.gov registry record
Microbiome, Antibiotics, and Growth Infant Cohort
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 509
- Enrollment target
NCT03001167: Completed study, sponsored by Children's Hospital of Philadelphia.
NCT03001167 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 509 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03001167 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 509 participants
- Enrollment target
Study Summary
This cross-disciplinary study will assemble and longitudinally follow a large, diverse birth cohort to determine the relationships between early life antibiotic exposure, microbiome development, growth, antibodies, and immunostimulation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 509 participants |
| Start Date | 2016-12-09 |
| Est. Completion | 2023-06-09 |
What the finished NCT03001167 record still lists
NCT03001167 is an observational study that tracks outcomes without assigning an intervention. The registered 509 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03001167 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03001167 about?
NCT03001167 is a clinical study titled "Microbiome, Antibiotics, and Growth Infant Cohort". This cross-disciplinary study will assemble and longitudinally follow a large, diverse birth cohort to determine the relationships between early life antibiotic exposure, microbiome development, growth, antibodies, and immunostimulation.
What is the current status of trial NCT03001167?
This trial is currently completed. The enrollment target is 509 participants. The study started on 2016-12-09. Estimated completion is 2023-06-09.
Who is sponsoring clinical trial NCT03001167?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
- NCT04634552 · 510 participants · Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- NCT05164744 · 510 participants
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
- NCT05451004 · 510 participants · Phase 3
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI